This HTML5 document contains 104 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73412852
rdf:type
wikibase:Item
schema:description
im Dezember 1999 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'avientu de 1999 article scientifique publié en 1999 wetenschappelijk artikel գիտական հոդված հրատարակված 1999 թվականի դեկտեմբերի 1-ին наукова стаття, опублікована в грудні 1999 scientific article published on 01 December 1999
p:P577
wds:Q73412852-65FED183-D952-4D41-9EF1-AC87D08CF3A0
wdt:P577
1999-12-01T00:00:00Z
p:P407
wds:Q73412852-76C5E09C-F2DF-4EA8-A98D-16FD499984D4
wdt:P407
wd:Q1860
p:P2860
wds:Q73412852-893515BE-CC28-4C4F-AD30-60FD31DB23AA wds:Q73412852-9FBB8B6A-0A5A-43BE-8B25-45C0E1A928F7 wds:Q73412852-7BFA60C5-D43B-42EF-B1A9-3668E5EE3EAD wds:Q73412852-7EF02EF2-6EEF-4E63-83F8-F9E8EED35DE4 wds:Q73412852-82402E9A-4ACF-4880-B97E-EDCDAB7A83DC wds:Q73412852-B087524B-C1E8-44C4-90F9-00111BC0F3AA wds:Q73412852-CDE0CF24-D8C2-4A9D-A715-A46BAF8D7D33 wds:Q73412852-A1ACF5E5-5528-44C0-8540-A307B595DA7E wds:Q73412852-A7D09187-0B79-482F-9C2A-B33F5478E4A6 wds:Q73412852-DDC05246-E2E8-4325-8F4D-D83F07E3843D wds:Q73412852-D2712F5C-BF4E-4C5B-87B9-DE76714DF67F wds:Q73412852-D7189CF7-C416-4248-BE8F-45B903EC5682 wds:Q73412852-DB1F0970-4C44-40FA-B510-3F8959FE8A08 wds:Q73412852-027E67D5-FECB-4E43-AC2F-AA64810202CF wds:Q73412852-0EEF0791-F6FA-42D5-9E86-25BAEA663A82 wds:Q73412852-266A4E80-4407-41DC-B9B6-132D7A5BC49C wds:Q73412852-00A12A29-A202-4595-91DD-7067DD9199C5 wds:Q73412852-44B1EA44-910E-4FBE-81FB-4C3D85DBF90B wds:Q73412852-49515E26-7F99-43C7-AC66-262721A4871D wds:Q73412852-4F886938-61D0-4650-AB95-D99F310E8CA0 wds:Q73412852-3C3DCB41-FAFB-4FBF-A4C5-3AFAA8F86347 wds:Q73412852-3E57CB19-A6A6-4050-AC1A-A03CDBA004C2 wds:Q73412852-5E10E277-3F61-4B31-999F-EB035E4ECEC3 wds:Q73412852-64402D04-6A3B-4D9A-B038-E7F26350ECFC
wdt:P2860
wd:Q47842239 wd:Q71144604 wd:Q72269453 wd:Q70530034 wd:Q36674977 wd:Q68018406 wd:Q29547165 wd:Q71718330 wd:Q74469123 wd:Q41643317 wd:Q54185242 wd:Q73528728 wd:Q55480769 wd:Q77674385 wd:Q53967667 wd:Q70676527 wd:Q70819594 wd:Q28369461 wd:Q73848865 wd:Q74080669 wd:Q73807471 wd:Q71720716 wd:Q68028661 wd:Q78015037
p:P2093
wds:Q73412852-A8B2921B-43FA-406B-B341-5F3150CD1D29 wds:Q73412852-A35C650B-FE68-4D87-B901-3204737C413D wds:Q73412852-D1890CCC-C343-4405-9503-4BADF6EE817C wds:Q73412852-CAC3E25F-5F27-469F-B054-B5B44661D928 wds:Q73412852-F0A797BE-CFDD-4B06-94FA-A7F78310F702 wds:Q73412852-6410687B-A67F-4D91-97E3-BCBFD0823325 wds:Q73412852-63939EB7-8660-460C-9518-8A78298BF06F wds:Q73412852-66FBCFD9-4063-497C-956C-01FD3E60A3B9 wds:Q73412852-7E7B57AE-BE85-4C21-9452-5D3ACC3F9E8D
wdt:P2093
M Nagata S Aoki J Yatsunami S Hayashi N Tsuruta Y Fukuno S Taniguchi M Tominaga M Kawashima
rdfs:label
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells
skos:prefLabel
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells
schema:name
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells
p:P1476
wds:Q73412852-85948820-2670-4405-8B60-01444B3DF8A8
wdt:P1476
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells
p:P304
wds:Q73412852-6499650D-5D2E-4096-9652-3B6F480F70B0
wdt:P304
17-24
p:P31
wds:Q73412852-449375B9-FDF7-4692-88D9-34108DC06225
wdt:P31
wd:Q13442814
p:P921
wds:Q73412852-8D4AB3C8-D236-4306-9E67-8BA0151E338E
wdt:P921
wd:Q118551
p:P698
wds:Q73412852-E58FDF72-D9BF-42C2-8CB3-185516F29403
wdtn:P698
n10:10660084
wdt:P698
10660084
p:P1433
wds:Q73412852-5D5CAD92-4C11-4608-8E62-DF09F092838D
wdt:P1433
wd:Q326372
p:P433
wds:Q73412852-1B576253-1D09-4855-88B9-49A720634AEB
p:P478
wds:Q73412852-DBAA0549-A976-4070-A26F-8173347085B6
wdt:P433
1-2
wdt:P478
147
p:P356
wds:Q73412852-28885CD1-4B27-44C7-AD47-B3187CFA94B7
wdtn:P356
n12:S0304-3835(99)00258-X
wdt:P356
10.1016/S0304-3835(99)00258-X